ACT Capital Management »

Axt shares owned by ACT Capital Management

Quarter-by-quarter ownership of Axt (AXTI) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Axt

Tip: Access up to 7 years of quarterly data

All positions including Axt held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axt by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $353k 4.9k 72.08

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Abivax Sa Sponsored Ads (ABVX)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Arrowhead Pharmaceuticals (ARWR)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Nektar Therapeutics Com New (NKTR)
Tesla Motors (TSLA)
Cytokinetics (CYTK)
Ast Spacemobile Com Cl A (ASTS)
Palvella Therapeutics Inc Ne (PVLA)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)

View all positions for ACT Capital Management

Top funds holding Axt

Susquehanna International
Jane Street
Vanguard Capital Management
E20 Capital
Citadel Advisors
Morgan Stanley
WT Asset Management
Anther Capital
E Fund Management
BlackRock
UBS Group
Assenagon Asset Management
Citigroup
Point72 Asset Management
Goldman Sachs Group

View all funds holding Axt